Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Yassine Kilani, Saqr Alsakarneh, Mahmoud Y. Madi, Daniel Alejandro Gonzalez Mosquera, Mariana Nunes Ferreira, Fouad Jaber, John Helzberg, Nikki Duong, Wing‐Kin Syn |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis
by: Saqr Alsakarneh, et al.
Published: (2025)
by: Saqr Alsakarneh, et al.
Published: (2025)
Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL‐17A Inhibitors: A Population‐Based Study
by: Saqr Alsakarneh, et al.
Published: (2025)
by: Saqr Alsakarneh, et al.
Published: (2025)
Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study
by: Pinelopi Arvaniti, et al.
Published: (2025)
by: Pinelopi Arvaniti, et al.
Published: (2025)
Letter on ‘Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study’
by: Muhammad Ibrahim Khalil, et al.
Published: (2025)
by: Muhammad Ibrahim Khalil, et al.
Published: (2025)
Editorial: Addressing Unmet Needs and Socioeconomic Disparity in Patients With Autoimmune Hepatitis
by: Seren Gedallovich, et al.
Published: (2024)
by: Seren Gedallovich, et al.
Published: (2024)
Editorial: Steroid‐Induced Diabetes in Autoimmune Hepatitis—A Call for Treatment Optimization
by: Pranab M. Barman
Published: (2026)
by: Pranab M. Barman
Published: (2026)
Letter: Drug‐Induced Autoimmune‐Like Hepatitis—A Trigger on the Disease Spectrum. Authors' Reply
by: Pinelopi Arvaniti, et al.
Published: (2025)
by: Pinelopi Arvaniti, et al.
Published: (2025)
Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’: Authors' Reply
by: Lukas Burghart, et al.
Published: (2026)
by: Lukas Burghart, et al.
Published: (2026)
Editorial: Steroid‐Induced Diabetes in Autoimmune Hepatitis—A Call for Treatment Optimisation. Authors' Reply
by: Sarah Flatley
Published: (2026)
by: Sarah Flatley
Published: (2026)
Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain‐DDR Study
by: Ana Alberola, et al.
Published: (2026)
by: Ana Alberola, et al.
Published: (2026)
Impact of Nucleos(t)ide Analogs on Major Clinical Outcomes in Patients With Chronic Hepatitis B: A 10‐Year French Nationwide Cohort Study
by: Laurent Lam, et al.
Published: (2024)
by: Laurent Lam, et al.
Published: (2024)
Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic Recompensation
by: Benedikt Silvester Hofer, et al.
Published: (2026)
by: Benedikt Silvester Hofer, et al.
Published: (2026)
Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis
by: Luke D. Tyson, et al.
Published: (2026)
by: Luke D. Tyson, et al.
Published: (2026)
Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet?
by: Joyce Wing Yan Mak
Published: (2025)
by: Joyce Wing Yan Mak
Published: (2025)
Treatment‐Free Outcomes Following Surgery for IBD : A Nationwide Cohort Study
by: Adam S. Faye, et al.
Published: (2025)
by: Adam S. Faye, et al.
Published: (2025)
Editorial: The Relevance of Hepatic Flares and Quantitative Hepatitis B Surface Antigen After Stopping HBV Polymerase Inhibitors
by: Stefan Mauss
Published: (2025)
by: Stefan Mauss
Published: (2025)
Letter: Combination Therapies With Vitamin E for Metabolic Dysfunction‐Associated Steatotic Liver Disease
by: Stergios A. Polyzos, et al.
Published: (2024)
by: Stergios A. Polyzos, et al.
Published: (2024)
A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation
by: Ellen Werner, et al.
Published: (2026)
by: Ellen Werner, et al.
Published: (2026)
Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non‐Liver Malignancies in Hepatitis B Endemic Areas
by: Yi‐Ping Hung, et al.
Published: (2024)
by: Yi‐Ping Hung, et al.
Published: (2024)
Editorial: The Relevance of Hepatic Flares and Quantitative Hepatitis B Surface Antigen After Stopping HBV Polymerase Inhibitors—Authors' Reply
by: Ying‐Nan Tsai, et al.
Published: (2025)
by: Ying‐Nan Tsai, et al.
Published: (2025)
Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting
by: Toni Herta, et al.
Published: (2024)
by: Toni Herta, et al.
Published: (2024)
Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono‐Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study
by: Raffaella Viganò, et al.
Published: (2025)
by: Raffaella Viganò, et al.
Published: (2025)
Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study
by: Carl Eriksson, et al.
Published: (2024)
by: Carl Eriksson, et al.
Published: (2024)
Women's Health Disorders in a Coeliac Disease Population After Diagnosis—A Nationwide Cohort Analysis
by: Rama Nanah, et al.
Published: (2025)
by: Rama Nanah, et al.
Published: (2025)
Risk Prediction of Early‐Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult Cohort
by: Seogsong Jeong, et al.
Published: (2026)
by: Seogsong Jeong, et al.
Published: (2026)
Letter: Predictors of Corticosteroid Response in Alcohol‐Related Hepatitis
by: Ewan Forrest, et al.
Published: (2025)
by: Ewan Forrest, et al.
Published: (2025)
Antibiotic Use and Risk of Microscopic Colitis in Older Adults: A Nationwide Self‐Controlled Case Series Study
by: Máté Szilcz, et al.
Published: (2025)
by: Máté Szilcz, et al.
Published: (2025)
Letter: Critical Insights on a Nationwide Cohort Study of Inflammatory Bowel Disease, Histological Activity and Fracture Risk
by: Saad Khan, et al.
Published: (2024)
by: Saad Khan, et al.
Published: (2024)
Tenofovir Alafenamide Therapy Throughout Pregnancy in Mothers With Hepatitis B
by: Xingfei Pan, et al.
Published: (2025)
by: Xingfei Pan, et al.
Published: (2025)
Surviving Hepatitis C—Understanding Death and Survival Beyond Cure
by: Paul J. Clark, et al.
Published: (2025)
by: Paul J. Clark, et al.
Published: (2025)
Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study
by: Samantha Baillie, et al.
Published: (2025)
by: Samantha Baillie, et al.
Published: (2025)
Editorial: Hepatitis C virus eradication improves skeletal muscle mass
by: Catherine Jia Lin Tian, et al.
Published: (2024)
by: Catherine Jia Lin Tian, et al.
Published: (2024)
Editorial: Advancing HCC Surveillance in Hepatitis B With Biomarker‐Based Strategy
by: Yu Jun Wong
Published: (2025)
by: Yu Jun Wong
Published: (2025)
Letter: Predictors of Corticosteroid Response in Alcohol‐Related Hepatitis—Authors' Reply
by: Francisco Idalsoaga, et al.
Published: (2025)
by: Francisco Idalsoaga, et al.
Published: (2025)
Editorial: Can We Prevent Inflammatory Bowel Disease?
by: Agnes Hiu Yan Ho, et al.
Published: (2025)
by: Agnes Hiu Yan Ho, et al.
Published: (2025)
Editorial: Treatments for inflammatory bowel disease across the age‐spectrum—Are they the same?
by: Agnes Hiu Yan Ho, et al.
Published: (2024)
by: Agnes Hiu Yan Ho, et al.
Published: (2024)
Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis
by: Mushfiqur R. Siddique, et al.
Published: (2025)
by: Mushfiqur R. Siddique, et al.
Published: (2025)
Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure
by: Charlotte Mouliade, et al.
Published: (2025)
by: Charlotte Mouliade, et al.
Published: (2025)
Letter: Addressing Gaps in Hospital‐Based Hepatitis C Screening—Insights and Recommendations
by: Zhen Deng, et al.
Published: (2025)
by: Zhen Deng, et al.
Published: (2025)
Editorial: Beyond Viral Eradication—Scrutinising Outcomes After Hepatitis C Cure
by: Wei‐Fan Hsu, et al.
Published: (2025)
by: Wei‐Fan Hsu, et al.
Published: (2025)
Similar Items
-
Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis
by: Saqr Alsakarneh, et al.
Published: (2025) -
Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL‐17A Inhibitors: A Population‐Based Study
by: Saqr Alsakarneh, et al.
Published: (2025) -
Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study
by: Pinelopi Arvaniti, et al.
Published: (2025) -
Letter on ‘Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study’
by: Muhammad Ibrahim Khalil, et al.
Published: (2025) -
Editorial: Addressing Unmet Needs and Socioeconomic Disparity in Patients With Autoimmune Hepatitis
by: Seren Gedallovich, et al.
Published: (2024)